{"organizations": [], "uuid": "1b279e120b13b914a900c7162a60ddd7ad09c7e2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-novo-nordisk-proposes-two-new-boar/brief-novo-nordisk-proposes-two-new-board-members-idUSFWN1QD0E6", "country": "US", "domain_rank": 408, "title": "BRIEF-Novo Nordisk Proposes Two New Board Members", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-23T09:19:00.000+02:00", "replies_count": 0, "uuid": "1b279e120b13b914a900c7162a60ddd7ad09c7e2"}, "author": "", "url": "https://www.reuters.com/article/brief-novo-nordisk-proposes-two-new-boar/brief-novo-nordisk-proposes-two-new-board-members-idUSFWN1QD0E6", "ord_in_thread": 0, "title": "BRIEF-Novo Nordisk Proposes Two New Board Members", "locations": [], "entities": {"persons": [{"name": "stine jacobsen", "sentiment": "none"}, {"name": "martin mackay", "sentiment": "none"}], "locations": [{"name": "alexion pharmaceuticals", "sentiment": "none"}, {"name": "us", "sentiment": "none"}], "organizations": [{"name": "brief-novo nordisk proposes two new board", "sentiment": "negative"}, {"name": "brief-novo nordisk proposes two new board membe", "sentiment": "negative"}, {"name": "astrazeneca plc", "sentiment": "none"}, {"name": "novo nordisk", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 23, 2018 / 7:19 AM / Updated 2 hours ago BRIEF-Novo Nordisk Proposes Two New Board Members Reuters Staff 1 Min Read Feb 23 (Reuters) - NOVO NORDISK: * SAYS ‍BOARD OF DIRECTORS PROPOSES ELECTION OF ANDREAS FIBIG AND MARTIN MACKAY AS NEW MEMBERS OF BOARD OF DIRECTORS AT ANNUAL GENERAL MEETING MARCH 22 * FIBIG IS CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF INTERNATIONAL FLAVORS & FRAGRANCES * MACKAY IS FORMER EXECUTIVE VICE PRESIDENT AND GLOBAL HEAD OF RESEARCH AND DEVELOPMENT AT ALEXION PHARMACEUTICALS, INC., US, AND HAS ALSO BEEN HEAD OF RESEARCH & DEVELOPMENT IN BOTH ASTRAZENECA PLC. AND PFIZER​ Further company coverage: (Reporting by Stine Jacobsen)", "external_links": [], "published": "2018-02-23T09:19:00.000+02:00", "crawled": "2018-02-23T09:34:45.013+02:00", "highlightTitle": ""}